Commitments and Contingencies - Securities Purchase and Licensing Agreement and April 2024 Agreement for Gelclair (Details)			3 Months Ended	9 Months Ended
	Apr. 12, 2024	Mar. 18, 2024 USD ($) $ / shares shares	Sep. 30, 2025 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2025 EUR (€)	Sep. 30, 2024 USD ($)
Long-term Purchase Commitment
Initial term of contract				5 years	5 years
Non-refundable license fee				$ 215,040	€ 200,000
Royalty expense			$ 39,000	$ 117,000
April 2024 Agreement for Gelclair
Long-term Purchase Commitment
Initial term of contract	5 years			5 years	5 years
Royalty expense				$ 134,000		$ 0
Gen
Long-term Purchase Commitment
Issuance of common stock (in shares) | shares		11,111
Purchase price of common stock (per shares) | $ / shares		$ 3
Gross proceeds from the issuance of common stock		$ 2,000,000
Deferred revenue recognized as revenue		$ 850,000
License granted				$ 128,000		$ 85,000
Initial term of contract		5 years